Article: Medicago's H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal Model.

Article: Medicago's H5N1 VLP Vaccine Provides Protection Against Multiple Strains of Avian Flu; - Cross-protection established against deadly Vietnam strain -.
Canadian Corporate News;  March 19, 2008 ;     593 words ......via COMTEX) -- Medicago Inc. (TSX VENTURE...Avian Influenza VLP vaccine ( H5N1 VLP vaccine...vaccinated with Medicago's H5N1 VLP vaccine were fully protected...of our H5N1 VLP vaccine. We expect to...Nathalie Landry, Medicago's VP Product...

Article: Medicago's H5N1 Pandemic Flu Vaccine Effective in Key Ferret Animal Model With Single Dose.
Canadian Corporate News;  June 3, 2008 ;     610 words ......via COMTEX) -- Medicago Inc. (TSX VENTURE...Avian Influenza VLP vaccine that was performed...of Medicago. Our VLP vaccine is one of the first...Nathalie Landry, Medicago's VP Product Development...The objective of Medicago's study was to...optimal dosage of its ...

Article: Medicago Announces 2008 First Quarter Results.(Financial report)
Canadian Corporate News;  May 28, 2008 ;     700+ words ......com and at www.medicago.com. Q1 2008 Highlights...Avian Influenza VLP vaccine provided 100% protection...lead product, a VLP vaccine candidate for H5N1...President and CEO of Medicago. Highlighting the...studies of its H5N1 VLP vaccine with a lethal challenge...study in ...

Article: Medicago initiates work on Swine Flu strain.
PR Newswire;  April 28, 2009 ;     562 words ......PRNewswire-FirstCall/ -- Medicago Inc. (TSX-V: MDG...laboratory work with its VLP vaccine technology to produce...Brisbane (H1N1). Medicago is keeping health...informed on its work. Medicago's H5N1 pandemic VLP vaccine has shown to be...lead H5N1 pandemic VLP ...

Article: Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza A (H1N1) Virus.
PR Newswire;  June 4, 2009 ;     700+ words ......towards producing Influenza A (H1N1) VLP vaccine for animal and human testing ROCKVILLE...evaluation of a virus-like particle (VLP) vaccine candidate against the novel influenza...Novavax has produced influenza A (H1N1) VLP vaccine against the strain recommended by the...

Article: HPV type 18 L1 VLP vaccine safe and immunogenic in women.
Science Letter;  November 2, 2004 ;     341 words ......human papillomavirus (HPV) type 18 L1 VLP vaccine was safe and immunogenic in women. Human...11, 16, 18) L1 virus-like particle (VLP) vaccine may substantially reduce the incidence...randomized to receive either HPV18 L1 VLP vaccine or placebo, said Kevin A. Ault at the...

Article: Novavax and the NIH Agree to Evaluate a Virus-like Particle (VLP) Vaccine Candidate Against the Novel Influenza a (H1N1) Virus.
Vaccine Weekly;  June 17, 2009 ;     518 words ......evaluation of a virus-like particle (VLP) vaccine candidate against the novel influenza...Novavax has produced influenza A (H1N1) VLP vaccine against the strain recommended by the...possible to construct and manufacture VLP vaccine against this new H1N1 influenza virus...

Article: Medicago announces collaboration with Acambis to evaluate vaccine production using Proficia(TM).
PR Newswire;  September 27, 2005 ;     293 words ...QUEBEC CITY, QC, Sept. 27 /PRNewswire/ -- Medicago, Inc. announced today the signature of an...expression of recombinant vaccines using Medicago's plant-based Proficia(TM) system. Medicago will receive milestone payments from Acambis...

Article: Medicago Earns $0.5 Million Milestone Payment From Fortune 100 Company.
Canadian Corporate News;  April 7, 2008 ;     372 words ......Apr 7, 2008 (Marketwire via COMTEX) -- Medicago Inc. (TSX VENTURE:MDG) today announced...important milestone. On February 7, 2008, Medicago entered into a second non-exclusive license...development and commercialization of Medicago's proprietary plant-based production...

Article: Medicago announces research collaboration with Bayer CropScience.
PR Newswire;  January 31, 2005 ;     541 words ...QUEBEC CITY, Jan. 31 /PRNewswire/ -- Medicago, Inc. announced today that it has entered...is to assess the feasibility of using Medicago's proprietary Proficia(TM) Protein Technology...CropScience. This agreement is important to Medicago because it validates the growing market...

Article: Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.(Research)(Clinical report)
Virology Journal;  October 28, 2008 ;     700+ words ......H5N1 influenza virus-like particle (VLP) vaccine in mice and ferret models [2, 3, 4]. This VLP vaccine does not require the use of any live...H5N1. A multivalent pandemic influenza VLP vaccine has not been investigated despite the...

Article: Medicago Completes cGMP Qualification of its Manufacturing Facility.
Canadian Corporate News;  April 16, 2008 ;     482 words ......Marketwire via COMTEX) -- Medicago Inc. (TSX VENTURE:MDG...qualification will allow Medicago to produce clinical grade...Virus-Like Particles ( VLP ) vaccine candidates and other influenza...program to advance our VLP pandemic influenza vaccine...Sheldon, President and CEO of ...

Article: Novavax Finalizes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial.(Clinical report)
Health & Beauty Close-Up;  May 16, 2009 ;     348 words ......placebo-controlled study is evaluating a VLP vaccine against the H3N2, H1N1, and B influenza...Phase II study evaluated a trivalent VLP vaccine against the seasonal influenza strains...injection of either a placebo or the VLP vaccine at doses of 15 mcg or 60 mcg per strain...

Article: Medicago welcomes Pierre Labbe to its team.
PR Newswire;  August 31, 2004 ;     413 words ...QUEBEC CITY, Aug. 31 /PRNewswire/ -- Medicago Inc. is pleased to announce the appointment...Officer. Mr. Labbe will be responsible for Medicago's financial and administrative activities...for the company. We welcome Pierre to Medicago at an exciting time in our corporate...